(CW) Curtiss-Wright - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NYSE (USA) | Market Cap: 26.042m USD | Total Return: 73.7% in 12m
Industry Rotation: +6.3
Avg Turnover: 167M
EPS Trend: 99.8%
Qual. Beats: 13
Rev. Trend: 99.7%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
Pead
Curtiss-Wright Corporation (NYSE: CW) is a global manufacturer of engineered products and services across three primary segments: Aerospace & Industrial, Defense Electronics, and Naval & Power. The company specializes in high-performance components, including embedded computing modules, flight test instrumentation, and nuclear reactor technologies for both commercial and military applications. Its portfolio extends to surface technology services, such as laser peening, and critical naval equipment like main coolant pumps and propulsion systems.
Operating within the Aerospace & Defense sector, the company relies heavily on multi-year government contracts and rigorous certification standards, which create high barriers to entry for competitors. The business model is characterized by long product lifecycles, particularly in the naval and nuclear power sectors where maintenance and repair services provide recurring revenue streams. For a deeper look into the companys valuation metrics and historical performance, consider reviewing the data on ValueRay.
Founded in 1929 and headquartered in Davidson, North Carolina, the firm maintains a diverse industrial footprint. Its Defense Electronics segment leverages commercial off-the-shelf (COTS) technology to reduce development costs for the U.S. Navy and other defense agencies. This technical expertise in harsh-environment electronics and severe-service valve technologies positions the company as a specialized provider for critical infrastructure and national security programs.
- Increased U.S. Navy procurement of Virginia and Columbia-class nuclear submarines
- Global nuclear power renaissance drives demand for reactor cooling technology
- Modular open systems architecture adoption boosts defense electronics revenue growth
- Commercial aerospace recovery accelerates demand for surface technologies and actuators
- Defense budget allocations for electronic warfare and tactical communications systems
| Net Income: 511.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.39 > 1.0 |
| NWC/Revenue: 19.73% < 20% (prev 26.33%; Δ -6.60% < -1%) |
| CFO/TA 0.13 > 3% & CFO 676.5m > Net Income 511.1m |
| Net Debt (804.9m) to EBITDA (745.3m): 1.08 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.1m) vs 12m ago -2.10% < -2% |
| Gross Margin: 37.17% > 18% (prev 0.37%; Δ 3.68k% > 0.5%) |
| Asset Turnover: 70.56% > 50% (prev 64.90%; Δ 5.66% > 0%) |
| Interest Coverage Ratio: 7.89 > 6 (EBITDA TTM 745.3m / Interest Expense TTM 42.9m) |
| A: 0.14 (Total Current Assets 2.07b - Total Current Liabilities 1.36b) / Total Assets 5.27b |
| B: 0.84 (Retained Earnings 4.43b / Total Assets 5.27b) |
| C: 0.07 (EBIT TTM 338.9m / Avg Total Assets 5.11b) |
| D: 1.62 (Book Value of Equity 4.29b / Total Liabilities 2.64b) |
| Altman-Z'' Score: 5.78 = AAA |
| DSRI: 0.97 (Receivables 996.3m/911.3m, Revenue 3.61b/3.21b) |
| GMI: 1.00 (GM 37.17% / 37.10%) |
| AQI: 0.94 (AQ_t 0.49 / AQ_t-1 0.53) |
| SGI: 1.12 (Revenue 3.61b / 3.21b) |
| TATA: -0.03 (NI 511.1m - CFO 676.5m) / TA 5.27b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
Over the past week, the price has changed by -3.24%, over one month by -0.46%, over three months by +2.75% and over the past year by +73.71%.
- StrongBuy: 5
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 763.3 | 5% |
P/E Forward = 28.4091
P/S = 7.2209
P/B = 10.0039
P/EG = 1.9966
Revenue TTM = 3.61b USD
EBIT TTM = 338.9m USD
EBITDA TTM = 745.3m USD
Long Term Debt = 757.6m USD (from longTermDebt, last quarter)
Short Term Debt = 200.0m USD (from shortTermDebt, last quarter)
Debt = 1.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 804.9m USD (from netDebt column, last quarter)
Enterprise Value = 26.85b USD (26.04b + Debt 1.15b - CCE 343.4m)
Interest Coverage Ratio = 7.89 (Ebit TTM 338.9m / Interest Expense TTM 42.9m)
EV/FCF = 45.44x (Enterprise Value 26.85b / FCF TTM 590.8m)
FCF Yield = 2.20% (FCF TTM 590.8m / Enterprise Value 26.85b)
FCF Margin = 16.38% (FCF TTM 590.8m / Revenue TTM 3.61b)
Net Margin = 14.17% (Net Income TTM 511.1m / Revenue TTM 3.61b)
Gross Margin = 37.17% ((Revenue TTM 3.61b - Cost of Revenue TTM 2.27b) / Revenue TTM)
Gross Margin QoQ = 36.28% (prev 37.53%)
Tobins Q-Ratio = 5.09 (Enterprise Value 26.85b / Total Assets 5.27b)
Interest Expense / Debt = 0.87% (Interest Expense 9.94m / Debt 1.15b)
Taxrate = 18.75% (29.6m / 157.8m)
NOPAT = 275.4m (EBIT 338.9m * (1 - 18.75%))
Current Ratio = 1.52 (Total Current Assets 2.07b / Total Current Liabilities 1.36b)
Debt / Equity = 0.44 (Debt 1.15b / totalStockholderEquity, last quarter 2.63b)
Debt / EBITDA = 1.08 (Net Debt 804.9m / EBITDA 745.3m)
Debt / FCF = 1.36 (Net Debt 804.9m / FCF TTM 590.8m)
Total Stockholder Equity = 2.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.00% (Net Income 511.1m / Total Assets 5.27b)
RoE = 19.64% (Net Income TTM 511.1m / Total Stockholder Equity 2.60b)
RoCE = 10.09% (EBIT 338.9m / Capital Employed (Equity 2.60b + L.T.Debt 757.6m))
RoIC = 7.73% (NOPAT 275.4m / Invested Capital 3.56b)
WACC = 10.47% (E(26.04b)/V(27.19b) * Re(10.90%) + D(1.15b)/V(27.19b) * Rd(0.87%) * (1-Tc(0.19)))
Discount Rate = 10.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -1.69%
[DCF] Terminal Value 73.37% ; FCFF base≈549.0m ; Y1≈655.2m ; Y5≈1.04b
[DCF] Fair Price = 298.4 (EV 11.83b - Net Debt 804.9m = Equity 11.02b / Shares 36.9m; r=10.47% [WACC]; 5y FCF grow 20.62% → 3.0% )
EPS Correlation: 99.78 | EPS CAGR: 18.53% | SUE: 4.0 | # QB: 13
Revenue Correlation: 99.74 | Revenue CAGR: 10.37% | SUE: 2.32 | # QB: 2
EPS current Quarter (2026-06-30): EPS=3.58 | Chg30d=+0.39% | Revisions=+0% | Analysts=7
EPS next Quarter (2026-09-30): EPS=3.81 | Chg30d=+0.46% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=15.20 | Chg30d=+0.87% | Revisions=+56% | GrowthEPS=+14.8% | GrowthRev=+7.9%
EPS next Year (2027-12-31): EPS=16.94 | Chg30d=+0.83% | Revisions=+56% | GrowthEPS=+11.5% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +56%